139 related articles for article (PubMed ID: 32398249)
41. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
42. Choroidal osteoma - case reports.
Khan N; Rahman NA; Uddin MS
Mymensingh Med J; 2014 Jul; 23(3):599-602. PubMed ID: 25178620
[TBL] [Abstract][Full Text] [Related]
43. Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters.
Lee JH; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):645-51. PubMed ID: 26138657
[TBL] [Abstract][Full Text] [Related]
44. Paediatric choroidal osteoma treated with ranibizumab.
Vayalambrone D; Misra A
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23192581
[TBL] [Abstract][Full Text] [Related]
45. Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents.
Schworm B; Luft N; Keidel LF; Hagenau F; Kern C; Herold T; Kortuem KU; Priglinger SG; Siedlecki J
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1013-1021. PubMed ID: 32112141
[TBL] [Abstract][Full Text] [Related]
46. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
Sudhalkar A; Yogi R; Chhablani J
Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
[TBL] [Abstract][Full Text] [Related]
47. Choroidal Response to Anti-VEGF Therapy in Subgroups Classified by Preexisting Ophthalmic or Systemic Condition.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8364. PubMed ID: 26747766
[No Abstract] [Full Text] [Related]
48. Quantitative OCT subanalysis of eyes with choroidal neovascularization switched from multiple injections of bevacizumab or ranibizumab to intravitreal aflibercept.
Hariri A; Diniz B; Fou LV; Lam LA; Nittala MG; Sadda SR
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):195-200. PubMed ID: 25707044
[TBL] [Abstract][Full Text] [Related]
49. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
[TBL] [Abstract][Full Text] [Related]
50. Bilateral choroidal osteoma: long-term follow-up of secondary choroidal neovascularization in a child using antiangiogenic therapy.
Durá Gómez P; Català-Mora J; López-de-Eguileta A; Díaz-Cascajosa J
J AAPOS; 2024 Apr; 28(2):103869. PubMed ID: 38460597
[TBL] [Abstract][Full Text] [Related]
51. Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Zhang K; Chen Y; Sun X; Zhong Q; Lin L; Gao Y; Hong F
Medicine (Baltimore); 2018 Sep; 97(39):e12464. PubMed ID: 30278530
[TBL] [Abstract][Full Text] [Related]
52. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
53. SAVING SIGHT IN NEOVASCULAR AMD.
Retina; 2020 Jul; 40 Suppl 2():S1-S12. PubMed ID: 32558673
[No Abstract] [Full Text] [Related]
54. Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy.
Hernández-Martínez P; Dolz-Marco R; Alonso-Plasencia M; Abreu-Gonzalez R
Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1337-9. PubMed ID: 24789465
[No Abstract] [Full Text] [Related]
55. Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration.
Dirani A; Ambresin A; Marchionno L; Decugis D; Mantel I
Am J Ophthalmol; 2015 Oct; 160(4):732-8.e2. PubMed ID: 26144701
[TBL] [Abstract][Full Text] [Related]
56. Simulating an Anti-Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration: A HARBOR Subanalysis.
Zarbin M; Tsuboi M; Hill LF; Stoilov I
Ophthalmology; 2019 Jun; 126(6):849-855. PubMed ID: 30641096
[TBL] [Abstract][Full Text] [Related]
57. Optical coherence tomography angiography-guided photodynamic therapy for extrafoveal choroidal neovascularization.
Chawla R; Hasan N; Sundar D; Sharma A
Digit J Ophthalmol; 2020 Jan; 26(1):1-7. PubMed ID: 32547330
[TBL] [Abstract][Full Text] [Related]
58. Masquerade macular exudation in Mallatia Leventinese.
Ewe SY; Jamieson R; Chang AA
Can J Ophthalmol; 2016 Feb; 51(1):e27-9. PubMed ID: 26874169
[No Abstract] [Full Text] [Related]
59. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
Cheng Y; Li Y; Huang X; Qu Y
Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal ranibizumab for choroidal neovascularization secondary to gyrate atrophy in a young patient: a multimodal imaging analysis.
Chatziralli I; Theodossiadis G; Emfietzoglou I; Theodossiadis P
Eur J Ophthalmol; 2015 Oct; 25(6):e119-22. PubMed ID: 26419008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
